Michael Lane - 12 Feb 2026 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Executive Vice President
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Michael Lane
Issuer symbol
IDXX
Transactions as of
12 Feb 2026
Net transactions value
-$139,086
Form type
4
Filing time
17 Feb 2026, 19:30:50 UTC
Previous filing
08 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lane Michael Executive Vice President ONE IDEXX DRIVE, WESTBROOK /s/ Lily J. Lu, Attorney-in-Fact for Michael Lane 17 Feb 2026 0001740689

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $0 +204 +2.9% $0.000000 7,357 14 Feb 2026 Direct F1
transaction IDXX Common Stock Options Exercise $0 +220 +3% $0.000000 7,577 14 Feb 2026 Direct
transaction IDXX Common Stock Options Exercise $0 +301 +4% $0.000000 7,878 14 Feb 2026 Direct
transaction IDXX Common Stock Options Exercise $0 +367 +4.7% $0.000000 8,245 14 Feb 2026 Direct F2
transaction IDXX Common Stock Tax liability $139,086 -221 -2.7% $629.35 8,024 14 Feb 2026 Direct F3, F4
holding IDXX Common Stock 592 12 Feb 2026 by spouse F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Non-Qualified Stock Option (right-to-buy) Award $0 +5,361 $0.000000 5,361 12 Feb 2026 Common Stock 5,361 $617.20 Direct F6
transaction IDXX Incentive Stock Option (right-to-buy) Award $0 +162 $0.000000 162 12 Feb 2026 Common Stock 162 $617.20 Direct F7
transaction IDXX Restricted Stock Unit Award $0 +1,262 $0.000000 1,262 12 Feb 2026 Common Stock 1,262 Direct F8
transaction IDXX Restricted Stock Unit Award $0 +1,620 $0.000000 1,620 12 Feb 2026 Common Stock 1,620 Direct F9
transaction IDXX Restricted Stock Unit Options Exercise $0 -367 -25% $0.000000 1,101 14 Feb 2026 Common Stock 367 Direct F10
transaction IDXX Restricted Stock Unit Options Exercise $0 -204 -100% $0.000000 0 14 Feb 2026 Common Stock 204 Direct F11
transaction IDXX Restricted Stock Unit Options Exercise $0 -220 -50% $0.000000 220 14 Feb 2026 Common Stock 220 Direct F12
transaction IDXX Restricted Stock Unit Options Exercise $0 -301 -33% $0.000000 602 14 Feb 2026 Common Stock 301 Direct F13
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes a total of 21 shares purchased under the Issuer Employee Stock Purchase Plan ('ESPP') on September 30, 2025 and December 31, 2025. There are a total of 252.944 shares held in the ESPP which has been increased by 0.005 shares due to a rounding calculation of previously issued fractional shares.
F2 Represents Restricted Stock Units ('RSU') that were granted on February 14, 2025, were deferred in accordance with the Issuer's Deferred Compensation Plan and have vested. Upon vesting, these RSUs were recorded in an account under such Plan and represents a contingent right to receive one share of Issuer common stock that is payable as soon as practicable after the reporting person's termination of employment with the Issuer.
F3 Closing price of Issuer common stock on Nasdaq Global Select Market on February 13, 2026.
F4 Includes 367 vested but deferred RSUs.
F5 Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.
F6 Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2027.
F7 Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2030.
F8 Grant of RSUs that upon vesting, will be deferred and recorded in an account under the Issuer's Deferred Compensation Plan. This RSU grant vests in four annual installments, beginning February 14, 2027.
F9 Grant of RSUs that upon vesting, will be deferred and recorded in an account under the Issuer's Deferred Compensation Plan. This RSU grant vests in three annual installments, beginning February 14, 2027.
F10 Represents RSUs that were granted on February 14, 2025 and deferred in accordance with the Issuer's Deferred Compensation Plan and represents a contingent right to receive one share of Issuer common stock vesting in four annual installments, beginning February 14, 2026. Upon vesting, each such RSU will be recorded in an account under such Plan.
F11 Each RSU represents a contingent right to receive one share of Issuer common stock that vested in four annual installments, beginning February 14, 2023.
F12 Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024.
F13 Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025.